GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OSTO:CEVI) » Definitions » Days Sales Outstanding

CellaVision AB (OSTO:CEVI) Days Sales Outstanding : 53.09 (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is CellaVision AB Days Sales Outstanding?

CellaVision AB's average Accounts Receivable for the three months ended in Dec. 2024 was kr108.6 Mil. CellaVision AB's Revenue for the three months ended in Dec. 2024 was kr186.7 Mil. Hence, CellaVision AB's Days Sales Outstanding for the three months ended in Dec. 2024 was 53.09.

The historical rank and industry rank for CellaVision AB's Days Sales Outstanding or its related term are showing as below:

OSTO:CEVI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 45.07   Med: 53.07   Max: 73.21
Current: 50.6

During the past 13 years, CellaVision AB's highest Days Sales Outstanding was 73.21. The lowest was 45.07. And the median was 53.07.

OSTO:CEVI's Days Sales Outstanding is ranked better than
69.72% of 819 companies
in the Medical Devices & Instruments industry
Industry Median: 65.35 vs OSTO:CEVI: 50.60

CellaVision AB's Days Sales Outstanding increased from Dec. 2023 (42.42) to Dec. 2024 (53.09).


CellaVision AB Days Sales Outstanding Historical Data

The historical data trend for CellaVision AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Days Sales Outstanding Chart

CellaVision AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.92 51.88 53.48 52.66 50.63

CellaVision AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.42 47.99 45.26 56.08 53.09

Competitive Comparison of CellaVision AB's Days Sales Outstanding

For the Medical Devices subindustry, CellaVision AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellaVision AB's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Days Sales Outstanding falls into.



CellaVision AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

CellaVision AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (97.797 + 102.824) / 2 ) / 723.217*365
=100.3105 / 723.217*365
=50.63

CellaVision AB's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (114.421 + 102.824) / 2 ) / 186.688*365 / 4
=108.6225 / 186.688*365 / 4
=53.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellaVision AB  (OSTO:CEVI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


CellaVision AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


CellaVision AB Business Description

Traded in Other Exchanges
Address
Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers/software.

CellaVision AB Headlines

No Headlines